title: Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
authors.forename: D
authors.initials: D
authors.lastname: Roulston
authors.forename: J
authors.initials: J
authors.lastname: Anastasi
authors.forename: R
authors.initials: R
authors.lastname: Rudinsky
authors.forename: G
authors.initials: G
authors.lastname: Nucifora
authors.forename: N
authors.initials: N
authors.lastname: Zeleznik-Le
authors.forename: J D
authors.initials: JD
authors.lastname: Rowley
authors.forename: L
authors.initials: L
authors.lastname: McGavran
authors.forename: M
authors.initials: M
authors.lastname: Tsuchida
authors.forename: Y
authors.initials: Y
authors.lastname: Hayashi
mesh_terms: D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy / Q000235:genetics*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage; D019070:Cell Lineage; D002648:Child; D002675:Child, Preschool; D002880:Chromosomes, Human, Pair 11 / Q000648:ultrastructure*; D002891:Chromosomes, Human, Pair 21 / Q000648:ultrastructure*; D002898:Chromosomes, Human, Pair 8 / Q000648:ultrastructure*; D003561:Cytarabine / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000139:chemically induced / Q000235:genetics*; D008942:Mitoxantrone / Q000008:administration & dosage; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000235:genetics*; D009857:Oncogenes; D059005:Topoisomerase II Inhibitors; D014178:Translocation, Genetic
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone; D001215:Asparaginase